Literature DB >> 16155721

Prostate MR imaging at high-field strength: evolution or revolution?

Olivier Rouvière1, Robert P Hartman, Denis Lyonnet.   

Abstract

As 3 T MR scanners become more available, body imaging at high field strength is becoming the subject of intensive research. However, little has been published on prostate imaging at 3 T. Will high-field imaging dramatically increase our ability to depict and stage prostate cancer? This paper will address this question by reviewing the advantages and drawbacks of body imaging at 3 T and the current limitations of prostate imaging at 1.5 T, and by detailing the preliminary results of prostate 3 T MRI. Even if slight adjustments of imaging protocols are necessary for taking into account the changes in T1 and T2 relaxation times at 3 T, tissue contrast in T2-weighted (T2w) imaging seems similar at 1.5 T and 3 T. Therefore, significant improvement in cancer depiction in T2w imaging is not expected. However, increased spatial resolution due to increased signal-to-noise ratio (SNR) may improve the detection of minimal capsular invasion. Higher field strength should provide increased spectral and spatial resolution for spectroscopic imaging, but new pulse sequences will have to be designed for overcoming field inhomogeneities and citrate J-modulation issues. Finally, dynamic contrast-enhanced MRI is the method of imaging that is the most likely to benefit from the increased SNR, with a significantly better trade-off between temporal and spatial resolution.

Entities:  

Mesh:

Year:  2005        PMID: 16155721     DOI: 10.1007/s00330-005-2893-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  76 in total

1.  Imaging brain function in humans at 7 Tesla.

Authors:  E Yacoub; A Shmuel; J Pfeuffer; P F Van De Moortele; G Adriany; P Andersen; J T Vaughan; H Merkle; K Ugurbil; X Hu
Journal:  Magn Reson Med       Date:  2001-04       Impact factor: 4.668

2.  Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results.

Authors:  François Cornud; Thierry Flam; Laurent Chauveinc; Khaled Hamida; Yves Chrétien; Annick Vieillefond; Olivier Hélénon; Jean François Moreau
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

3.  Cardiac magnetic resonance parallel imaging at 3.0 Tesla: technical feasibility and advantages.

Authors:  Kiaran P McGee; Josef P Debbins; Ed B Boskamp; LeRoy Blawat; Lisa Angelos; Kevin F King
Journal:  J Magn Reson Imaging       Date:  2004-03       Impact factor: 4.813

4.  Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: zonal and age-related differences.

Authors:  M Lowry; G P Liney; L W Turnbull; D J Manton; S J Blackband; A Horsman
Journal:  Magn Reson Med       Date:  1996-09       Impact factor: 4.668

5.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.

Authors:  G J Jager; E T Ruijter; C A van de Kaa; J J de la Rosette; G O Oosterhof; J R Thornbury; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

6.  Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence--preliminary experience.

Authors:  M van der Graaf; H J van den Boogert; G J Jager; J O Barentsz; A Heerschap
Journal:  Radiology       Date:  1999-12       Impact factor: 11.105

7.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.

Authors:  K K Yu; J Scheidler; H Hricak; D B Vigneron; C J Zaloudek; R G Males; S J Nelson; P R Carroll; J Kurhanewicz
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

8.  Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images.

Authors:  E K Outwater; R O Petersen; E S Siegelman; L G Gomella; C E Chernesky; D G Mitchell
Journal:  Radiology       Date:  1994-11       Impact factor: 11.105

9.  Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.

Authors:  Fabian Kiessling; Matthias Lichy; Rainer Grobholz; Melanie Heilmann; Nabeel Farhan; Maurice Stephan Michel; Lutz Trojan; Joerg Ederle; Ulrich Abel; Hans-Ulrich Kauczor; Wolfhard Semmler; Stefan Delorme
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

10.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.

Authors:  Michael Mullerad; Hedvig Hricak; Liang Wang; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

View more
  20 in total

1.  Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score.

Authors:  Ullrich G Mueller-Lisse; Mark G Swanson; Daniel B Vigneron; John Kurhanewicz
Journal:  Eur Radiol       Date:  2006-06-22       Impact factor: 5.315

2.  Eye imaging with a 3.0-T MRI using a surface coil--a study on volunteers and initial patients with uveal melanoma.

Authors:  Arne-Jörn Lemke; Minouche Alai-Omid; Susanne Anja Hengst; Iris Kazi; Roland Felix
Journal:  Eur Radiol       Date:  2006-01-06       Impact factor: 5.315

3.  Diffusion tensor imaging of the normal prostate at 3 Tesla.

Authors:  Bengi Gürses; Neslihan Kabakci; Arzu Kovanlikaya; Zeynep Firat; Ali Bayram; Aziz Müfit Uluğ; Aziz Müfit Uluo; Ilhami Kovanlikaya
Journal:  Eur Radiol       Date:  2007-10-25       Impact factor: 5.315

4.  Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements.

Authors:  Gregory J Metzger; Carl Snyder; Can Akgun; Tommy Vaughan; Kamil Ugurbil; Pierre-Francois Van de Moortele
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

5.  Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance.

Authors:  Larissa J Vos; Michele Janoski; Keith Wachowicz; Atiyah Yahya; Oleksandr Boychak; John Amanie; Nadeem Pervez; Matthew B Parliament; Edith Pituskin; B Gino Fallone; Nawaid Usmani
Journal:  World J Radiol       Date:  2016-04-28

6.  Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.

Authors:  Liang Wang
Journal:  World J Radiol       Date:  2009-12-31

7.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 8.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

Review 9.  MR imaging of the prostate in clinical practice.

Authors:  Yousef Mazaheri; Amita Shukla-Dave; Ada Muellner; Hedvig Hricak
Journal:  MAGMA       Date:  2008-09-16       Impact factor: 2.310

10.  Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy.

Authors:  Alexandre Ben Cheikh; Nicolas Girouin; Marc Colombel; Jean-Marie Maréchal; Albert Gelet; Alvine Bissery; Muriel Rabilloud; Denis Lyonnet; Olivier Rouvière
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.